PDI announces changes to the Super Sani-Cloth® Germicidal Disposable Wipes master label, including EPA acceptance on kill claims for three key microorganisms: Bordetella pertussis, Enterobacter cloacae (NDM-1 Positive) and Klebsiella pneumoniae (KPC-2 positive, multi-drug and carbapenem resistant). The formulation of Super-Sani Cloth has not changed. Additional label enhancements include listing isopropyl alcohol as an active ingredient and improved language in the directions for use.
“With this announcement, our partners can feel even more confident that PDI products meet and exceed the highest clinical standards and regulatory guidelines," says Melanie Kupperman, product manager for Sani-Cloth®. “We continue to innovate both products and packaging so healthcare facilities have the best technology available to help in the fight against multi-drug resistant organisms and healthcare-associated infections.”
Super Sani-Cloth® is tested effective against 30 microorganisms with a contact time of two minutes, making it ideal for fast-paced environments that require quick room turnover. It is formulated to serve as a house-wide solution for disinfecting high-touch, non-porous surfaces and is compatible with a broad range of equipment. It is available in multiple sizes including a large canister (6” x 6.75” wipe), extra-large canister (7.5” X 15” wipe), large individual packets (5” x 8” wipe) and extra-large individual packets (11.5” x 11.75” wipe).
The Sani-Cloth® line from PDI includes Super Sani-Cloth®, Sani-Cloth® AF3, and Sani-Cloth® Bleach. Complemented by PDI’s range of compliance tools, ongoing clinical support and comprehensive implementation training for staff, the San-Cloth Environmental Hygiene system offers a complete solution for house-wide and situational use.
Source: PDI
The Role of Environmental Hygiene in Preventing Antimicrobial Resistance
March 19th 2024Uncover the pivotal role of environmental hygiene in thwarting antimicrobial resistance (AMR) for infection prevention teams. Learn how rigorous cleaning protocols and advanced technologies enhance patient safety and combat AMR.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.